Feng Jiang

机构：Jiangsu Cancer Hospital, Second Affiliated Hospital of Nanjing Medical University, Second Affiliated Hospital of Zhejiang University, Nanjing Medical University · ORCID：0000-0001-6569-5956

发表论文 304 篇 · 总被引 8249 次 · h-index 46

代表论文

• Unveiling biomarkers via plasma metabolome profiling for diabetic macrovascular and microvascular complications (2025 · Cardiovascular Diabetology · 被引 6)
• The N6-methyladenosine-mediated cLMNB1 degrades FGFR4 to overcome osimertinib resistance in non-small cell lung cancer (2025 · Cell Death and Disease · 被引 4)
• Expert Consensus on Subxiphoid and Subcostal Arch Thoracoscopic Resection for the Treatment of Thymoma (2025 · Thoracic Cancer · 被引 4)
• ALCAM-CD6 axis suppression: a key determinant of immune-mediated metastasis recurrence in stage III non-small cell lung cancer (2025 · Journal for ImmunoTherapy of Cancer · 被引 3)
• Targeting the MPO/LCN2/GMPPB axis in IBS-depression comorbidity: Integrated multi-omics and bidirectional network pharmacology for precision diagnostics and therapeutics (2026 · Computational Biology and Chemistry · 被引 2)
• Suppressing the OTUD7A/KDM5B/GABPA axis enhances the sensitivity of cisplatin through inducing ferroptosis in KRAS-mutant LUAD (2025 · Cell Death and Disease · 被引 2)